On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage List since 2022 because demand for ...
Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...
Makers of copycat versions of Novo Nordisk's (NVO) popular weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing the FDA for removing the GLP-1 medication from its shortage list.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback